| Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity E Liu, Y Tong, G Dotti, H Shaim, B Savoldo, M Mukherjee, J Orange, ... Leukemia 32 (2), 520-531, 2018 | 686 | 2018 |
| Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells M Daher, R Basar, E Gokdemir, N Baran, N Uprety, AK Nunez Cortes, ... Blood, The Journal of the American Society of Hematology 137 (5), 624-636, 2021 | 203 | 2021 |
| Phase I study of cord blood‐derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma N Shah, L Li, J McCarty, I Kaur, E Yvon, H Shaim, M Muftuoglu, E Liu, ... British journal of haematology 177 (3), 457-466, 2017 | 191 | 2017 |
| Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells H Shaim, M Shanley, R Basar, M Daher, J Gumin, DB Zamler, N Uprety, ... The Journal of Clinical Investigation 131 (14), 2021 | 165 | 2021 |
| Allogeneic BK virus–specific T cells for progressive multifocal leukoencephalopathy M Muftuoglu, A Olson, D Marin, S Ahmed, V Mulanovich, S Tummala, ... New England Journal of Medicine 379 (15), 1443-1451, 2018 | 159 | 2018 |
| Combining AFM13, a bispecific CD30/CD16 antibody, with cytokine-activated blood and cord blood–derived NK cells facilitates CAR-like responses against CD30+ malignancies LN Kerbauy, ND Marin, M Kaplan, PP Banerjee, MM Berrien-Elliott, ... Clinical Cancer Research 27 (13), 3744-3756, 2021 | 108 | 2021 |
| Clinical efficacy and tumor microenvironment influence in a dose-escalation study of anti-CD19 chimeric antigen receptor T cells in refractory B-cell non-Hodgkin's lymphoma ZX Yan, LI Li, W Wang, BS OuYang, S Cheng, L Wang, W Wu, PP Xu, ... Clinical Cancer Research 25 (23), 6995-7003, 2019 | 95 | 2019 |
| KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape Y Li, R Basar, G Wang, E Liu, JS Moyes, L Li, LN Kerbauy, N Uprety, ... Nature medicine 28 (10), 2133-2144, 2022 | 82 | 2022 |
| Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation T Sekine, D Marin, K Cao, L Li, P Mehta, H Shaim, C Sobieski, R Jones, ... Blood, The Journal of the American Society of Hematology 128 (2), 297-312, 2016 | 70 | 2016 |
| Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering L Li, V Mohanty, J Dou, Y Huang, PP Banerjee, Q Miao, JG Lohr, ... Science Advances 9 (30), eadd6997, 2023 | 40 | 2023 |
| Bi-order multimodal integration of single-cell data J Dou, S Liang, V Mohanty, Q Miao, Y Huang, Q Liang, X Cheng, S Kim, ... Genome biology 23 (1), 112, 2022 | 39 | 2022 |
| GMP-compliant universal antigen presenting cells (uAPC) promote the metabolic fitness and antitumor activity of armored cord blood CAR-NK cells E Liu, SOT Ang, L Kerbauy, R Basar, I Kaur, M Kaplan, L Li, Y Tong, ... Frontiers in immunology 12, 626098, 2021 | 39 | 2021 |
| The cXcr4–sTaT3–il-10 Pathway controls the immunoregulatory Function of chronic lymphocytic leukemia and is Modulated by lenalidomide H Shaim, Z Estrov, D Harris, M Hernandez Sanabria, Z Liu, P Ruvolo, ... Frontiers in immunology 8, 1773, 2018 | 34 | 2018 |
| Microbiological and clinical studies of legionellosis in 33 patients with cancer XY Han, A Ihegword, SE Evans, J Zhang, L Li, H Cao, JJ Tarrand, ... Journal of Clinical Microbiology 53 (7), 2180-2187, 2015 | 34 | 2015 |
| A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantation L Li, H Chen, D Marin, Y Xi, Q Miao, J Lv, PP Banerjee, H Shaim, M Daher, ... Blood Advances 3 (23), 4117-4130, 2019 | 33 | 2019 |
| Transgenic expression of IL-7 regulates CAR-T cell metabolism and enhances in vivo persistence against tumor cells L Li, Q Li, ZX Yan, LS Sheng, D Fu, P Xu, L Wang, WL Zhao Scientific reports 12 (1), 12506, 2022 | 32 | 2022 |
| Large-scale GMP-compliant CRISPR-Cas9–mediated deletion of the glucocorticoid receptor in multivirus-specific T cells R Basar, M Daher, N Uprety, E Gokdemir, A Alsuliman, E Ensley, G Ozcan, ... Blood advances 4 (14), 3357-3367, 2020 | 32 | 2020 |
| A subset of virus-specific CD161+ T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML A Alsuliman, M Muftuoglu, A Khoder, YO Ahn, R Basar, MR Verneris, ... Blood, The Journal of the American Society of Hematology 129 (6), 740-758, 2017 | 29 | 2017 |
| The TGF-β/SMAD signaling pathway as a mediator of NK cell dysfunction and immune evasion in myelodysplastic syndrome M Daher, R Basar, H Shaim, E Gokdemir, N Uprety, A Kontoyiannis, ... Blood 130, 53, 2017 | 22 | 2017 |
| Characterizing cancer metabolism from bulk and single-cell RNA-seq data using METAFlux Y Huang, V Mohanty, M Dede, K Tsai, M Daher, L Li, K Rezvani, K Chen Nature communications 14 (1), 4883, 2023 | 18 | 2023 |
